RUNX2 and ocular melanoma: These proteins are upregulated in osteogenesis (Figure 5(b), control), and treatment with 0.3 μM biochanin A demonstrated significantly enhanced OPG, Runx2, and RhoA protein expression in OM, compared with control cells (P < 0.05) (Figure 5(b)).